BlossomHill Therapeutics, Inc. ($BLSM)
Filing Information
| Accession Number | 0001231919-26-000852 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 10, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
6,939,472
Total Value
$5,000,000.00
P&L
+9.3% (+$463,200.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 10, 2026 | Conversion | 1,599,993 | โ | โ | 1,599,993 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Conversion | 1,701,541 | โ | โ | 3,301,534 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Aug 10, 2026 | Purchase | 312,500 | $16.00 | $5,000,000.00 | 3,614,034 | Indirect | See footnotes | View Details | |
Director | Director Stock Option (Right to Buy) | Derivative | Aug 6, 2026 | Grant/Award | 23,904 | $0.00 | $0.00 | 23,904 | Direct | โ | View Details | |
Director | Series A Preferred Stock | Derivative | Aug 10, 2026 | Conversion | 1,599,993 | โ | โ | 0 | Indirect | See footnotes | View Details | |
Director | Series B Preferred Stock | Derivative | Aug 10, 2026 | Conversion | 1,701,541 | โ | โ | 0 | Indirect | See footnotes | View Details |